2.65
price up icon2.32%   0.06
after-market 시간 외 거래: 2.65
loading
전일 마감가:
$2.59
열려 있는:
$2.61
하루 거래량:
2.83M
Relative Volume:
0.75
시가총액:
$568.85M
수익:
$12.87M
순이익/손실:
$-114.34M
주가수익비율:
-3.065
EPS:
-0.8646
순현금흐름:
$-79.23M
1주 성능:
+3.11%
1개월 성능:
+8.61%
6개월 성능:
+74.34%
1년 성능:
+16.74%
1일 변동 폭
Value
$2.525
$2.675
1주일 범위
Value
$2.34
$2.745
52주 변동 폭
Value
$1.05
$3.31

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name
명칭
Taysha Gene Therapies Inc
Name
전화
(214) 612-0000
Name
주소
3000 PEGASUS PARK DRIVE, DALLAS
Name
직원
73
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TSHA's Discussions on Twitter

TSHA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TSHA
Taysha Gene Therapies Inc
2.65 677.36M 12.87M -114.34M -79.23M -0.8646
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-11 개시 BofA Securities Buy
2024-06-27 개시 BMO Capital Markets Outperform
2024-04-09 개시 Piper Sandler Overweight
2023-02-01 다운그레이드 Jefferies Buy → Hold
2023-01-27 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-11-09 다운그레이드 Goldman Buy → Neutral
2022-03-09 개시 Robert W. Baird Outperform
2022-03-01 개시 Wells Fargo Overweight
2022-02-18 개시 SMBC Nikko Outperform
2021-12-16 개시 Guggenheim Buy
2021-07-16 개시 Needham Buy
2021-06-24 개시 Truist Buy
2021-06-15 개시 BTIG Research Buy
2021-06-09 개시 Wedbush Outperform
2021-06-08 개시 JMP Securities Mkt Outperform
2021-05-19 개시 Cantor Fitzgerald Overweight
2021-05-11 재개 Jefferies Buy
2021-02-24 개시 William Blair Outperform
2021-01-05 개시 Oppenheimer Outperform
2020-10-19 개시 Chardan Capital Markets Buy
2020-10-19 개시 Goldman Buy
2020-10-19 개시 Jefferies Buy
2020-10-19 개시 Morgan Stanley Overweight
모두보기

Taysha Gene Therapies Inc 주식(TSHA)의 최신 뉴스

pulisher
10:06 AM

What are analysts’ price targets for Taysha Gene Therapies Inc. in the next 12 monthsFree Stock Chart Pattern Guide - jammulinksnews.com

10:06 AM
pulisher
07:45 AM

What are the technical indicators suggesting about Taysha Gene Therapies Inc.Unlock powerful trading tools for investors - jammulinksnews.com

07:45 AM
pulisher
05:29 AM

Why is Taysha Gene Therapies Inc. stock attracting strong analyst attentionBuild wealth steadily with proven strategies - jammulinksnews.com

05:29 AM
pulisher
Jul 26, 2025

How Taysha Gene Therapies Inc. stock performs during market volatility200 Percent Profit Outlook - Metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

Taysha Gene Therapies Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Taysha Gene Therapies Inc. a good long term investmentLightning-fast growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Can Taysha Gene Therapies Inc. stock recover from recent declineConsistently profitable trades - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Taysha Gene Therapies Inc. stockFree Capital Growth Strategies - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Rett bet set includes Neurogene, Taysha gene therapies - BioWorld MedTech

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Taysha Gene Therapies Inc. stock priceUnrivaled growth potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Leigh Syndrome Market Research Report 2025-2035 | Competitive Analysis of PTC Therapeutics, Pharming Group, Edison Pharmaceuticals, Taysha Gene Therapies, and Thiogenesis Therapeutics - Yahoo Finance

Jul 22, 2025
pulisher
Jul 17, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $8.17 Consensus PT from Analysts - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

Taysha Gene Therapies (TSHA) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Jul 16, 2025
pulisher
Jul 15, 2025

Why Taysha Gene Therapies Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Taysha Gene Therapies Inc. stock price move sharplyFree Long-Term Wealth Growth Plan - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

How did TSHA's Q1 2024 EPS surprise impact short-term traders? - AInvest

Jul 13, 2025
pulisher
Jul 13, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Coverage Initiated at Bank of America - Defense World

Jul 13, 2025
pulisher
Jul 12, 2025

Biotech Bargains: Finding Gold in the Healthcare Sell-Off - AInvest

Jul 12, 2025
pulisher
Jul 11, 2025

Taysha Gene's 5.9% Surge: A Deep Dive into the Unexplained Rally - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

BofA Securities initiates coverage on Taysha Gene Therapies stock with Buy rating - Investing.com Canada

Jul 11, 2025
pulisher
Jul 11, 2025

BofA Assigns Buy Rating to Taysha Gene Therapies (TSHA) with $8 Target | TSHA Stock News - GuruFocus

Jul 11, 2025
pulisher
Jul 10, 2025

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - MSN

Jul 10, 2025
pulisher
Jul 08, 2025

Goldman Sachs Group Inc's Strategic Acquisition in Taysha Gene Therapies Inc - GuruFocus

Jul 08, 2025
pulisher
Jul 03, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Li - GuruFocus

Jul 03, 2025
pulisher
Jul 03, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 03, 2025
pulisher
Jul 03, 2025

Taysha Gene Therapies (TSHA) Gets a Buy from Wells Fargo - The Globe and Mail

Jul 03, 2025
pulisher
Jul 01, 2025

Beyond The Numbers: 10 Analysts Discuss Taysha Gene Therapies Stock - Nasdaq

Jul 01, 2025
pulisher
Jul 01, 2025

Taysha Gene Therapies (TSHA) Receives Buy Rating from Needham | - GuruFocus

Jul 01, 2025
pulisher
Jul 01, 2025

Taysha Gene Therapies (TSHA) Receives Buy Rating from Needham | TSHA Stock News - GuruFocus

Jul 01, 2025

Taysha Gene Therapies Inc (TSHA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):